MeSH term
Frequency | Condition_Probility | Adult | 2 | 0.0 |
Female | 3 | 0.0 |
Humans | 15 | 0.0 |
Male | 7 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Animals | 13 | 0.0 |
Base Sequence | 10 | 0.0 |
Comparative Study | 5 | 0.0 |
Exons | 3 | 0.0 |
Introns | 3 | 0.0 |
Mice | 9 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Nerve Tissue Proteins/*genetics | 3 | 0.0 |
RNA-Binding Proteins/*genetics | 4 | 3.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Gene Expression | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Blotting, Western | 2 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
RNA-Binding Proteins/metabolism | 2 | 2.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Fragile X Syndrome/*genetics | 4 | 2.0 |
Mental Retardation/*genetics | 3 | 1.0 |
Rabbits | 2 | 0.0 |
Xenopus laevis | 2 | 0.0 |
Fragile X Syndrome/genetics | 2 | 6.0 |
Mice, Knockout | 2 | 0.0 |
Brain/metabolism | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Hela Cells | 4 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Nerve Tissue Proteins/genetics/*metabolism | 2 | 1.0 |
Fragile X Syndrome/genetics/*metabolism | 2 | 33.0 |
Nerve Tissue Proteins/*biosynthesis/genetics | 2 | 4.0 |
RNA-Binding Proteins/*biosynthesis/genetics | 2 | 40.0 |
Cell Line | 2 | 0.0 |
Mutation | 2 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |